Avodart is a prescription medication used primarily to treat benign prostatic hyperplasia in men. It belongs to a class of drugs known as 5-alpha-reductase inhibitors. The active ingredient, dutasteride, blocks the enzyme that converts testosterone into dihydrotestosterone. By lowering dihydrotestosterone levels, the drug reduces prostate tissue growth. This shrinkage of the prostate can improve urinary symptoms such as frequency and difficulty urinating. In addition, the decrease in dihydrotestosterone slows hair follicle miniaturization, helping to preserve hair in male pattern baldness. The medication is taken orally in capsule form, usually once daily. Its therapeutic effects result from the sustained reduction of dihydrotestosterone in target tissues.

Avodart is a synthetic 5-alpha-reductase inhibitor that blocks the conversion of testosterone into dihydrotestosterone. By reducing dihydrotestosterone levels in the prostate, it decreases the size of the gland and improves urinary flow. The diminished dihydrotestosterone also lessens stimulation of hair follicles that leads to male pattern baldness. The medication's pharmacokinetic profile shows high lipophilicity, extensive protein binding, and metabolism primarily through hepatic oxidation. After oral administration it reaches steady-state concentrations within weeks, providing sustained inhibition of the enzyme. The resulting clinical effect is a slower progression of benign prostatic hyperplasia symptoms without altering androgen production elsewhere.

Avodart may cause decreased libido or erectile dysfunction in some patients. It can also lead to breast tenderness or enlargement. Some individuals experience dizziness or lightheadedness. Mood changes such as depression or anxiety have been reported. The medication might affect liver function tests. These effects are generally reversible after discontinuation.

Avodart is a prescription medication that inhibits the conversion of testosterone to dihydrotestosterone. As with many drugs it can cause changes in sexual function including reduced libido and difficulty achieving orgasm. Some users report breast tenderness or enlargement that may require medical evaluation. Rarely the drug may lead to dizziness or fainting especially when standing up quickly. Elevated liver enzymes have been observed in a small number of patients during routine testing. Mood alterations such as depression or anxiety have been reported in isolated cases. Allergic skin reactions including rash or itching can occur in susceptible individuals. These effects illustrate that the medication influences hormonal pathways and may affect multiple organ systems.